CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Being the top BSE gainer, shares of this pharmaceutical company were locked at the 20 per cent upper circuit! Do you own it?
DSIJ Intelligence
/ Categories: Trending, Mindshare

Being the top BSE gainer, shares of this pharmaceutical company were locked at the 20 per cent upper circuit! Do you own it?

In such a weak market, its strong price-volume breakout kept the bulls in the small-cap sector busy.

The Indian headline indices ended the session lower amid weak global cues. All sectors were trading down, with BSE Auto, BSE Consumer Discretionary and BSE Consumer Durables sectors bearing the brunt of the damage.  

BSE Healthcare was one of the worst performing sectors, ending 0.77 per cent lower, dragged down by shares of Aurobindo Pharma, which lost more than 11 per cent. While the majority of pharmaceutical stocks fell, investors were drawn to Neuland Laboratories by its robust upswing.   

Following the release of its Quarterly Results, shares of Neuland Laboratories, the top BSE Smallcap gainer, skyrocketed and were locked at a 20 per cent upper circuit with a 21-fold rise in volume. In such a weak market, its strong price-volume breakout kept the bulls in the Small-Cap sector busy. 

The total revenue was Rs 293.9 crore in Q2FY23, reflecting a boost of 13.9 per cent year-on-year, while the net profit soared significantly to Rs 38.3 crore, a growth of 88.6 per cent.  

For over 38 years, the company has been at the forefront of API manufacturing, working with customers in nearly 80 countries through its cGMP manufacturing facilities. Neuland Laboratories has created over 300 processes and 75 APIs, as well as filed over 900 regulatory filings in the United States, the European Union (EU) and other countries. 

Keep a close eye on this scrip for the upcoming sessions.  

Next Article Street Talk
Print
868 Rate this article:
4.7
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR